Variations of the Radioallergosorbent Test for Measurement of IgE Antibody Levels, Allergens and Blocking Antibody Activity

1981 ◽  
pp. 98-107 ◽  
Author(s):  
G. J. Gleich ◽  
J. W. Yunginger
Allergy ◽  
1991 ◽  
Vol 46 (8) ◽  
pp. 632-638 ◽  
Author(s):  
M. Blanca ◽  
C. Mayorga ◽  
F. Sanchez ◽  
J. M. Vega ◽  
J. Fernandez ◽  
...  

Parasitology ◽  
1994 ◽  
Vol 109 (1) ◽  
pp. 11-17 ◽  
Author(s):  
G. R. R. Ranawaka ◽  
A. R. Alejo-Blanco ◽  
R. E. Sinden

SUMMARYThe transmission-blocking monoclonal antibody 13.1, which recognizes the ookinete surface antigen Pbs21 ofPlasmodium berghei, and an IgG2a isotype control antibody 26.37 were purified by caprylic acid and ammonium sulphate precipitation. Fab fragments were prepared by papain digestion. IgG but not Fab from antibody 13.1 reduced ookinete formation byP. bergheiin culture by as much as 94% at a concentration of 100 μg/ml. There was little difference in antibody efficacy in the range 6·25–400 μg/ml in this assay. The parasite was most sensitive to antibody activity in the first 6–9 h of culture, i.e. the gamete/zygote and early retort stages. Peripheral blood leucocytes (PBL) were essential to achieve maximal inhibition by mAb 13.1 (activity was abrogated totally if PBL were removed). Together the data suggest that one of the mechanisms of action of this antibody is antibody-mediated PBL killing. Phagocytosis of parasites was noted in these experiments in all cultures. We have not attempted in this study to distinguish between Fc-mediated opsonization, as opposed to antibody-dependent cellular cytotoxicity.


Author(s):  
A.J. Terhell ◽  
S. Wahyuni ◽  
A. Pryce ◽  
J.W.M. Koot ◽  
K. Abadi ◽  
...  
Keyword(s):  

2020 ◽  
Vol 145 (2) ◽  
pp. AB220
Author(s):  
Sofianne Gabrielli ◽  
Ann Clarke ◽  
Alexandra Langlois ◽  
Sarah De Schryver ◽  
Moshe Ben-Shoshan

1988 ◽  
Vol 82 (1) ◽  
pp. 86-94 ◽  
Author(s):  
Masanao Shibasaki ◽  
Kimio Tajima ◽  
Akihiro Morikawa ◽  
Masato Mitsuhashi ◽  
Ryo Sumazaki ◽  
...  

1986 ◽  
Vol 95 (3_part_1) ◽  
pp. 307-311 ◽  
Author(s):  
Richard J. Trevino

In this study, there were three groups of patients—each group consisting of four patients. The first group had been skin tested by the scratch method, the second group was skin tested by the end point titration intradermal method, and the third group had been tested for inhalant allergy by the modified RAST technique. All of them had multiple treatment vials made, dependent on the type of testing they had, and the vials all included the ten inhalants that were tested for. All patients had been treated for a year with weekly immunotherapy injections. Specific IgG levels, blocking antibody levels to the ten inhalant allergens, were determined. The results were that the patients who had been scratch tested had the lowest levels of specific IgG blocking antibody—while both intradermal end point titration and modified RAST testing had much higher elevations of blocking IgG antibody, with the RAST having the highest. It is concluded that, since the treatment vials prepared after scratch testing of all the antigens are at the same concentration, there are many antigens that are not given in adequate amounts to cause a good IgG response whereas, by calibrating the concentrations of antigens in the intradermal titration and the modified RAST testing, all the antigens are being injected in sufficient quantities to get a good blocking antibody response.


Sign in / Sign up

Export Citation Format

Share Document